A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
Clinical trial NCT05848700 · COMPLETED
Trial details
- NCT number
- NCT05848700
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2024-03-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.